Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Plos One
|
September 17, 2013
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer
Florent Baty, Sacha Rothschild, Martin Früh, et al.
Clinical Lung Cancer
|
May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)
Martin Früh, Richard Cathomas, Marco Siano, et al.
Pediatrics
|
July 31, 2020
Developing Content for Pediatric Hospital Medicine Certification Examination Using Practice Analysis
Vineeta Mittal, Neha Shah, Andrew C Dwyer, et al.
Cancer Reports (Hoboken, N.J.)
|
June 1, 2026
Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus-Associated Disorders
Kandice Roberts, Paula Valiño Ramos, Saurabh Jindal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)
Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study
Sacha I Rothschild, Daniel Betticher, Reinhard Zenhäusern, et al.
The Prostate
|
July 27, 2016
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)
Richard Cathomas, Simon J Crabb, Michael Mark, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 27, 2012
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05)
Francesco Zappa, Cornelia Droege, Daniel Betticher, et al.
Clinical Lung Cancer
|
December 21, 2016
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial
Oliver Gautschi, Sacha I Rothschild, Qiyu Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2017
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
Roger von Moos, Dieter Koeberle, Sabina Schacher, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Plos One
|
September 17, 2013
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer
Florent Baty, Sacha Rothschild, Martin Früh, et al.
Clinical Lung Cancer
|
May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)
Martin Früh, Richard Cathomas, Marco Siano, et al.
Pediatrics
|
July 31, 2020
Developing Content for Pediatric Hospital Medicine Certification Examination Using Practice Analysis
Vineeta Mittal, Neha Shah, Andrew C Dwyer, et al.
Cancer Reports (Hoboken, N.J.)
|
June 1, 2026
Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus-Associated Disorders
Kandice Roberts, Paula Valiño Ramos, Saurabh Jindal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)
Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study
Sacha I Rothschild, Daniel Betticher, Reinhard Zenhäusern, et al.
The Prostate
|
July 27, 2016
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)
Richard Cathomas, Simon J Crabb, Michael Mark, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 27, 2012
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05)
Francesco Zappa, Cornelia Droege, Daniel Betticher, et al.
Clinical Lung Cancer
|
December 21, 2016
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial
Oliver Gautschi, Sacha I Rothschild, Qiyu Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2017
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
Roger von Moos, Dieter Koeberle, Sabina Schacher, et al.
Page
of 6